We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Virtual Heart Technology Guides Cardiac Ablation Procedures

By HospiMedica International staff writers
Posted on 04 Oct 2018
A new study describes how personalized three-dimensional (3D) simulations can pinpoint infarct-related ventricular tachycardia (VT) ablation sites.

Developed by researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Simula Research Laboratory (Simula; Fornebu, Norway), the University of Utah (Salt Lake City, USA), and other institutions, the 3D personalized computational models are based on contrast-enhanced clinical magnetic resonance imaging (MRI) cardiac scans, with each virtual tissue cell generating electrical signals calculated using mathematical equations to represent which heart cells are healthy, and which are semiviable due to proximity to the infarction scar.

By stimulating the patient’s virtual heart, the computer program can determine if the heart develops an arrhythmia, and the location of the tissue perpetuating it. More...
The 3D model can then simulate an ablation to that area. The procedure can be repeated over and over again to find multiple ablation locations for the actual patient. For the study, the researchers first created personalized heart models of 21 people who underwent successful cardiac ablation procedures for infarct-related VT at JHU Hospital between 2006 and 2017. The 3D modeling correctly identified and predicted ablation sites.

In five of the patients, the amount of ablated tissue identified by the 3D model was smaller overall--in some cases, more than 10 times smaller--than the actual area destroyed during the procedures. The researchers then tested the 3D simulation to guide actual cardiac ablation treatments for another five patients. Most patients have remained free of VT throughout the follow-up period. In two patients, the virtual heart approach predicted that tachycardias would not be inducible, which was confirmed during the clinical procedure, so cardiac ablation was not performed. The study was published on September 3, 2018, in Nature Biomedical Engineering.

“Our new study results suggest we can remove a lot of the guesswork, standardize treatment, and decrease the variability in outcomes, so that patients remain free of arrhythmia in the long term,” said senior author Professor Natalia Trayanova, PhD, of the JHU department of biomedical engineering. “The approach could improve infarct-related VT ablation guidance, where accurate identification of patient-specific optimal targets could be achieved on a personalized virtual heart before the clinical procedure.”

In VT, the electrical signals in the heart’s lower chambers misfire, crippling the relaxation and refilling process and producing rapid arrhythmias. Numerous drugs are available to treat and manage infarct-related VT, but side effects and limitations of the drugs have increased focus on other interventions, especially cardiac ablation, which is successful anywhere between 50 and 88 percent of the time, but the outcomes are difficult to predict.

Related Links:
Johns Hopkins University
Simula Research Laboratory
University of Utah

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.